CAPURSO, GABRIELE
 Distribuzione geografica
Continente #
EU - Europa 962
AS - Asia 754
NA - Nord America 735
SA - Sud America 8
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.463
Nazione #
US - Stati Uniti d'America 729
SG - Singapore 362
CN - Cina 337
SE - Svezia 332
RU - Federazione Russa 250
IT - Italia 230
FI - Finlandia 32
IE - Irlanda 25
DE - Germania 24
FR - Francia 16
HK - Hong Kong 15
IN - India 13
NL - Olanda 13
GB - Regno Unito 11
BR - Brasile 8
TW - Taiwan 8
IR - Iran 6
CA - Canada 4
CZ - Repubblica Ceca 4
RO - Romania 4
TR - Turchia 4
UA - Ucraina 4
BE - Belgio 3
PT - Portogallo 3
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
ES - Italia 2
IQ - Iraq 2
JP - Giappone 2
MX - Messico 2
PL - Polonia 2
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 2.463
Città #
Singapore 244
Shanghai 145
Ashburn 104
Moscow 88
Lawrence 85
Princeton 85
Milan 71
Dallas 66
Boardman 65
New York 62
Helsinki 26
Dublin 25
Washington 22
Rome 20
Guangzhou 18
Majano 18
Seattle 15
Hong Kong 13
Beijing 11
Jiaxing 11
Los Angeles 11
Shenzhen 11
London 10
Pune 10
Amsterdam 8
Santa Clara 8
Vaprio d'Adda 8
Columbus 7
Chang-hua 6
Lappeenranta 6
Mountain View 6
Munich 6
Verona 6
Carlsbad 5
Clifton 5
Ancona 4
Bergamo 4
Bologna 4
Florence 4
Monza 4
St Petersburg 4
Thousand Oaks 4
Xi'an 4
Brussels 3
Genoa 3
Kyiv 3
Oakville 3
Paris 3
Strasbourg 3
Verdellino 3
Villa Guardia 3
Wenzhou 3
Wuxi 3
Acireale 2
Austin 2
Baghdad 2
Barcelona 2
Bari 2
Berlin 2
Bern 2
Cagliari 2
Cambridge 2
Canberra 2
Civitavecchia 2
Commessaggio 2
Cordenons 2
Coriano 2
Dalian 2
Fort Worth 2
Guiyang 2
Huzhou 2
Kassel 2
Kish 2
Krakow 2
Lanciano 2
Landshut 2
Lecco 2
Miami 2
New Delhi 2
Nizhniy Novgorod 2
Osio Sopra 2
Pisa 2
Porto 2
Quanzhou 2
Redwood City 2
Rimini 2
Rio de Janeiro 2
Romainville 2
Saint-Denis 2
San Francisco 2
San Maurizio Canavese 2
Shijiazhuang 2
Stuttgart 2
São Paulo 2
Taipei 2
Teramo 2
Tulln 2
Turin 2
Uppsala 2
Zhengzhou 2
Totale 1.463
Nome #
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 57
Asymptomatic Chronic Elevation of Serum Pancreatic Enzymes: How to Deal with It? 46
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 33
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 27
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 26
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 26
High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures 26
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 25
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 25
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 24
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 24
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 24
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk 24
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 23
The impact of nutritional status on pancreatic cancer therapy 23
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 23
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 23
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 23
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 23
European evidence-based guidelines on pancreatic cystic neoplasms 22
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 22
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 22
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression 21
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 21
Artificial intelligence in EUS for autoimmune pancreatitis: Bias and real life 21
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 20
Urgent manifestations of immunoglobulin G4-related disease 20
Update on gastroenteropancreatic neuroendocrine tumors 20
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 20
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 20
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 19
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 19
Infection Control Practices and Outcomes of Endoscopy Units in the Lombardy Region of Italy: A Survey From the Italian Society of Digestive Endoscopy During COVID-19 Spread 19
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 19
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 19
The EFFect of dietary fat content on the recurrence of pancreaTitis (EFFORT): Protocol of a multicenter randomized controlled trial: Protocol of the EFFORT randomized trial: dietary fat reduction and pancreatitis recurrence 18
Delay in Pancreatic Endoscopic Ultrasound during the COVID-19 Pandemic in a Pancreas/Tertiary Referral Center 18
Consensus guidelines on severe acute pancreatitis 18
Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence? 18
Genetic and non-genetic risk factors for early-onset pancreatic cancer 17
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 17
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 17
Risk factors for the occurrence of ampullary tumors: A case-control study 17
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 17
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 17
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 17
The i-EUS consensus on the management of pancreatic fluid collections – Part 1 17
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency 17
Genome-wide association study identifies an early onset pancreatic cancer risk locus 17
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 17
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 16
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 16
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 16
Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations 16
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 16
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 16
Slow-pull compared to suction technique for EUS-guided sampling of pancreatic solid lesions: a meta-analysis of randomized controlled trials 16
Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis 16
How to get away with COVID-19: endoscopy during post-peak pandemic. A perspective review 16
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 16
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 15
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 15
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 15
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 15
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer 15
Endosonography-guided radiofrequency ablation in pancreatic diseases: Time to fill the gap between evidence and enthusiasm 15
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 15
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk 14
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 14
Exocrine pancreatic insufficiency in diabetic patients. prevalence, mechanisms, and treatment 14
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer 14
Diagnostic performance of Endoscopic Ultrasound Through-The-Needle microforceps Biopsy (EUS-TTNB) of pancreatic cystic lesions: a systematic review with meta-analysis 14
MYC up-regulation confers resistance to everolimus and establishes vulnerability to cyclin dependent kinase inhibitors in pancreatic neuroendocrine neoplasms cells 14
Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: An international multicentre study 14
Machine learning for the prediction of post-ERCP Pancreatitis risk: A proof-of-concept study 14
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 13
Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohort study 13
The use of ace inhibitors influences the risk of progression of BD-IPMNs under follow-up 13
Correction to: Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature? (Clinical and Translational Gastroenterology, (2018), 9, 6, (158), 10.1038/s41424-018-0026-3) 13
Pancreatic cyst surveillance imposes low psychological burden 13
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study 13
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 13
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 13
Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients with Autoimmune Pancreatitis: Systematic Review and Meta-analysis 12
A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH 12
ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma 12
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma 12
Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms 12
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals 12
Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study 12
Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study 12
Chronic Asymptomatic Pancreatic Hyperenzymemia (CAPH): Meta-analysis of pancreatic findings at second-level imaging 12
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 11
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 11
Alcohol and gastrointestinal cancers 11
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 11
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer 11
Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 11
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. 11
SECONDARY CANCERS IN PATIENTS WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS (IPMN): PRELIMINARY RESULTS OF A PROSPECTIVE MULTICENTRE ITALIAN STUDY 11
Totale 1.785
Categoria #
all - tutte 49.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.182


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 0 30 0 0 0 0 0
2020/202145 0 0 0 0 26 15 3 0 1 0 0 0
2021/202269 0 0 1 29 9 2 4 3 10 3 2 6
2022/2023642 196 114 47 1 10 80 78 63 30 2 12 9
2023/20241.058 48 36 81 256 70 149 46 111 18 29 65 149
2024/20251.027 512 138 88 130 159 0 0 0 0 0 0 0
Totale 2.881